Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis.
Agyemang N, Scarsi KK, Baker P, Smeaton LM, Podany AT, Olefsky M, Woolley E, Barr E, Pham M, Mawlana S, Supparatpinyo K, Gatechompol S, Jalil EM, Gadama L, Badal-Faesen S, Van Schalkwyk M, Kayama C, Belaunzaran-Zamudio PF, Godfrey C, Cohn SE, Mngqibisa R, Haas DW; AIDS Clinical Trials Group A5375 Study Team. Agyemang N, et al. Among authors: haas dw. Pharmacogenet Genomics. 2023 Aug 1;33(6):126-135. doi: 10.1097/FPC.0000000000000501. Epub 2023 Jun 12. Pharmacogenet Genomics. 2023. PMID: 37306344 Free PMC article.
Pharmacogenetics of tenofovir clearance among Southern Africans living with HIV.
Cindi Z, Kawuma AN, Maartens G, Bradford Y, Sokhela S, Chandiwana N, Venter WDF, Wasmann RE, Denti P, Wiesner L, Ritchie MD, Haas DW, Sinxadi P. Cindi Z, et al. Among authors: haas dw. Pharmacogenet Genomics. 2023 Jun 1;33(4):79-87. doi: 10.1097/FPC.0000000000000495. Epub 2023 Mar 6. Pharmacogenet Genomics. 2023. PMID: 37098852 Free PMC article. Clinical Trial.
Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans.
Mateza S, Bradford Y, Maartens G, Sokhela S, Chandiwana NC, Venter WDF, Post FA, Ritchie MD, Haas DW, Sinxadi P. Mateza S, et al. Among authors: haas dw. Pharmacogenet Genomics. 2023 Jul 1;33(5):91-100. doi: 10.1097/FPC.0000000000000491. Epub 2023 Apr 24. Pharmacogenet Genomics. 2023. PMID: 37099271 Free PMC article. Clinical Trial.
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection.
Grinspoon SK, Fitch KV, Zanni MV, Fichtenbaum CJ, Umbleja T, Aberg JA, Overton ET, Malvestutto CD, Bloomfield GS, Currier JS, Martinez E, Roa JC, Diggs MR, Fulda ES, Paradis K, Wiviott SD, Foldyna B, Looby SE, Desvigne-Nickens P, Alston-Smith B, Leon-Cruz J, McCallum S, Hoffmann U, Lu MT, Ribaudo HJ, Douglas PS; REPRIEVE Investigators. Grinspoon SK, et al. N Engl J Med. 2023 Aug 24;389(8):687-699. doi: 10.1056/NEJMoa2304146. Epub 2023 Jul 23. N Engl J Med. 2023. PMID: 37486775 Free PMC article. Clinical Trial.
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial.
Lu MT, Ribaudo H, Foldyna B, Zanni MV, Mayrhofer T, Karady J, Taron J, Fitch KV, McCallum S, Burdo TH, Paradis K, Hedgire SS, Meyersohn NM, DeFilippi C, Malvestutto CD, Sturniolo A, Diggs M, Siminski S, Bloomfield GS, Alston-Smith B, Desvigne-Nickens P, Overton ET, Currier JS, Aberg JA, Fichtenbaum CJ, Hoffmann U, Douglas PS, Grinspoon SK; REPRIEVE Trial Writing Group. Lu MT, et al. JAMA Cardiol. 2024 Apr 1;9(4):323-334. doi: 10.1001/jamacardio.2023.5661. JAMA Cardiol. 2024. PMID: 38381407 Free PMC article.
Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort.
Amorim G, Jaworski J, Yang J, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Turner M, Andrade BB, Velez Edwards DR, Santos AR, Rolla VC, Sterling TR, Haas DW; Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil network. Amorim G, et al. Among authors: haas dw. Pharmacogenet Genomics. 2024 Oct 15. doi: 10.1097/FPC.0000000000000552. Online ahead of print. Pharmacogenet Genomics. 2024. PMID: 39470346
Genetic ancestry proportion influences risk of adverse events from tuberculosis treatment in Brazil.
Piekos JA, Amorim G, Ridolfi F, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Andrade BB, Santos AR, Haas DW, Sterling TR, Rolla VC, Edwards DRV; Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil consortium. Piekos JA, et al. Among authors: haas dw. medRxiv [Preprint]. 2024 Aug 30:2024.08.29.24312595. doi: 10.1101/2024.08.29.24312595. medRxiv. 2024. PMID: 39252933 Free PMC article. Preprint.
Estimating optimal therapeutic drug levels of anti-tuberculosis medications based on treatment safety and effectiveness.
Amorim G, Haas DW, Cordeiro-Santos M, Kritski AL, Figueiredo MC, Staats C, Hachey B, Turner M, Andrade BB, Rolla VC, Sterling TR; Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil network. Amorim G, et al. Among authors: haas dw. medRxiv [Preprint]. 2024 Aug 31:2024.08.30.24312723. doi: 10.1101/2024.08.30.24312723. medRxiv. 2024. PMID: 39252925 Free PMC article. Preprint.
257 results